Stratifying risk in acute myeloid leukemia, daratumumab plus chemotherapy in relapsed-refractory pediatric leukemias, and a method for creating genetically engineered platelets
Blood Podcast
00:00
Next Steps for Daratumumab Combinations in Pediatrics
Commentators recommend further trials to define timing, first-line potential, and efficacy in extramedullary disease.
Play episode from 11:43
Transcript
